Ignite Creation Date:
2025-12-24 @ 3:25 PM
Ignite Modification Date:
2026-02-02 @ 9:46 AM
Study NCT ID:
NCT02142192
Status:
TERMINATED
Last Update Posted:
2024-06-03
First Post:
2014-05-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Natalizumab Subcutaneous Immunogenicity and Safety Study
Sponsor:
Organization: